丙型肝炎感染患者持续病毒学应答后的管理
Management of Hepatitis C-Infected Patients After Sustained Virological Response.
作者信息
Pearlman Brian
机构信息
Center for Hepatitis C Wellstar Atlanta Medical Center Atlanta GA.
Department of Medicine Medical College of Georgia Augusta GA.
出版信息
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):20-24. doi: 10.1002/cld.913. eCollection 2020 Jul.
Abstract
Watch an interview with the author Answer questions and earn CME.
摘要
观看对作者的采访，回答问题并获得继续医学教育学分。
相似文献
1
Management of Hepatitis C-Infected Patients After Sustained Virological Response.丙型肝炎感染患者持续病毒学应答后的管理
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):20-24. doi: 10.1002/cld.913. eCollection 2020 Jul.
2
Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management.小儿胆汁淤积症：流行病学、遗传学、诊断及当前治疗方法
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):115-119. doi: 10.1002/cld.895. eCollection 2020 Mar.
3
Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer.将非酒精性脂肪性肝炎与癌症联系起来的分子机制
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):6-10. doi: 10.1002/cld.1006. eCollection 2021 Jan.
4
Diagnostic performance of real-time tissue elastography in chronic hepatitis C patients with sustained virological response.实时组织弹性成像技术在慢性丙型肝炎病毒持续应答患者中的诊断性能。
Eur J Gastroenterol Hepatol. 2020 May;32(5):609-615. doi: 10.1097/MEG.0000000000001539.
5
Effects of hepatitis C virus genotypes and viral load on glucose and lipid metabolism after sustained virological response with direct-acting antivirals.直接作用抗病毒药物治疗实现持续病毒学应答后丙型肝炎病毒基因型和病毒载量对糖脂代谢的影响。
Rev Assoc Med Bras (1992). 2023 May 19;69(5):e20221163. doi: 10.1590/1806-9282.20221163. eCollection 2023.
6
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.肝移植受者治疗复发丙型肝炎后持续病毒学应答的长期维持。
Dig Liver Dis. 2014 May;46(5):440-5. doi: 10.1016/j.dld.2014.01.157. Epub 2014 Mar 11.
7
Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin.聚乙二醇干扰素α-2a（40KD）联合利巴韦林治疗慢性丙型肝炎患者持续病毒学应答的预测
Scand J Gastroenterol. 2007 Feb;42(2):247-55. doi: 10.1080/00365520600955526.
8
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.聚乙二醇化干扰素α-2a和α-2b联合利巴韦林治疗慢性丙型肝炎：系统评价与经济学评估
Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. doi: 10.3310/hta8390.
9
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.干扰素联合利巴韦林治疗初治5型丙型肝炎病毒患者的疗效。一项法国多中心回顾性研究。
Aliment Pharmacol Ther. 2006 Aug 15;24(4):593-600. doi: 10.1111/j.1365-2036.2006.03018.x.
10
Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection.HBeAg 阳性慢性乙型肝炎感染患者口服抗病毒药物停药后的持续病毒学应答和复发。
Front Immunol. 2022 Nov 25;13:1082091. doi: 10.3389/fimmu.2022.1082091. eCollection 2022.
本文引用的文献
1
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新：美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
2
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.HCV 诱导的与肝癌风险相关的表观遗传变化在持续病毒学应答后仍然存在。
Gastroenterology. 2019 Jun;156(8):2313-2329.e7. doi: 10.1053/j.gastro.2019.02.038. Epub 2019 Mar 2.
3
The Changing Scenario of Screening and Surveillance of Esophageal Varices.食管静脉曲张筛查与监测的变化情况
Gastroenterology. 2019 Mar;156(4):864-866. doi: 10.1053/j.gastro.2019.02.011. Epub 2019 Feb 15.
4
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.Baveno VI 标准在代偿期肝硬化和持续抗病毒治疗应答患者食管静脉曲张筛查和监测中的验证。
Gastroenterology. 2019 Mar;156(4):997-1009.e5. doi: 10.1053/j.gastro.2018.11.053. Epub 2019 Feb 13.
5
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.直接作用抗病毒治疗后慢性丙型肝炎患者的临床结局：一项前瞻性队列研究。
Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.
6
Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.肝癌筛查可提高肝硬化患者的生存率。
Clin Gastroenterol Hepatol. 2019 Apr;17(5):976-987.e4. doi: 10.1016/j.cgh.2018.10.031. Epub 2018 Oct 26.
7
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.直接作用抗病毒药物诱导的丙型肝炎病毒清除可降低肝细胞癌的风险。
J Hepatol. 2017 Sep 5. doi: 10.1016/j.jhep.2017.08.030.
8
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.在西欧 HIV 阳性男男性行为者中 HCV 再感染发生率和自发清除率。
J Hepatol. 2017 Feb;66(2):282-287. doi: 10.1016/j.jhep.2016.09.004. Epub 2016 Sep 17.
9
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.丙型肝炎肝硬化患者获得持续病毒学应答后的生存率与普通人群相似。
J Hepatol. 2016 Jun;64(6):1217-23. doi: 10.1016/j.jhep.2016.01.034. Epub 2016 Apr 5.
10
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.治疗活跃性注射毒品人群中的丙型肝炎病毒感染：系统评价和荟萃分析。
Clin Infect Dis. 2013 Aug;57 Suppl 2:S80-9. doi: 10.1093/cid/cit306.
Zotero 插件